Urogen Pharma Stock Price on December 31, 2024
| URGN Stock | USD 12.13 0.11 0.92% |
If you're considering investing in UroGen Stock, it is important to understand the factors that can impact its price. As of today, the current price of UroGen Pharma stands at 12.13, as last reported on the 22nd of March, with the highest price reaching 12.20 and the lowest price hitting 11.80 during the day. UroGen Pharma appears to be somewhat reliable, given 3 months investment horizon. UroGen Pharma owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0859, which indicates the firm had a 0.0859 % return per unit of risk over the last 3 months. We have found thirty technical indicators for UroGen Pharma, which you can use to evaluate the volatility of the company. Please review UroGen Pharma's Coefficient Of Variation of 1164.39, semi deviation of 2.92, and Risk Adjusted Performance of 0.0831 to confirm if our risk estimates are consistent with your expectations.
UroGen Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
UroGen |
Sharpe Ratio = 0.0859
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | URGN | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.9 actual daily | 25 75% of assets are more volatile |
Expected Return
| 0.25 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average UroGen Pharma is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of UroGen Pharma by adding it to a well-diversified portfolio.
Related Headline
Erasca Headline on 31st of December 2024
Acquisition by Bristol James Arthur of 45678 shares of Erasc... by Bristol James Arthur
Filed transaction by Erasca Inc Director. Grant, award or other acquisition pursuant to Rule 16b-3(d)
UroGen Pharma Valuation on December 31, 2024
It is possible to determine the worth of UroGen Pharma on a given historical date. On December 31, 2024 UroGen was worth 10.69 at the beginning of the trading date compared to the closed value of 10.65. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of UroGen Pharma stock. Still, in general, we apply an absolute valuation method to find UroGen Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of UroGen Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against UroGen Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 10.70 | 10.91 | 10.38 | 10.52 | 426,422 | |
12/31/2024 | 10.69 | 10.83 | 10.42 | 10.65 | 478,340 |
| 10.80 | 11.21 | 10.51 | 10.70 | 560,535 |
| Backtest UroGen Pharma | | | UroGen Pharma History | | | UroGen Pharma Valuation | Previous | Next |
UroGen Pharma Trading Date Momentum on December 31, 2024
| On January 02 2025 UroGen Pharma was traded for 10.70 at the closing time. The top price for the day was 11.21 and the lowest listed price was 10.51 . The trading volume for the day was 560.5 K. The trading history from January 2, 2025 was a factor to the next trading day price boost. The trading price change against the next closing price was 0.47% . The trading price change against the current closing price is 2.82% . |
UroGen Pharma Fundamentals Correlations and Trends
By evaluating UroGen Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among UroGen Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. UroGen financial account trend analysis is a perfect complement when working with valuation or volatility modules.About UroGen Pharma Stock history
UroGen Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for UroGen is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in UroGen Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing UroGen Pharma stock prices may prove useful in developing a viable investing in UroGen Pharma
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey. Urogen Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 201 people.
UroGen Pharma Stock Technical Analysis
UroGen Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
UroGen Pharma Period Price Range
Low | March 22, 2025
| High |
0.00 | 0.00 |
UroGen Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
UroGen Pharma March 22, 2025 Market Strength
Market strength indicators help investors to evaluate how UroGen Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading UroGen Pharma shares will generate the highest return on investment. By undertsting and applying UroGen Pharma stock market strength indicators, traders can identify UroGen Pharma entry and exit signals to maximize returns
UroGen Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for UroGen Pharma's price direction in advance. Along with the technical and fundamental analysis of UroGen Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of UroGen to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0831 | |||
| Jensen Alpha | 0.2914 | |||
| Total Risk Alpha | 0.4593 | |||
| Sortino Ratio | 0.0952 | |||
| Treynor Ratio | 0.3074 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in UroGen Pharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in UroGen Stock, please use our How to Invest in UroGen Pharma guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UroGen Pharma. If investors know UroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UroGen Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of UroGen Pharma is measured differently than its book value, which is the value of UroGen that is recorded on the company's balance sheet. Investors also form their own opinion of UroGen Pharma's value that differs from its market value or its book value, called intrinsic value, which is UroGen Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UroGen Pharma's market value can be influenced by many factors that don't directly affect UroGen Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UroGen Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if UroGen Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UroGen Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.